Results 21 to 30 of about 364,087 (292)
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
BMC Endocrine Disorders, 2018 Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning +2 more
doaj +1 more source
Riedel Thyroiditis in a Patient with Graves Disease [PDF]
Endocrinology and Metabolism, 2013 Riedel's thyroiditis is a rare form of infiltrative and inflammatory disease of the thyroid gland and can be associated with systemic fibrotic processes, Hashimoto thyroiditis and Graves disease.
Doo Young Lee +4 more
doaj +1 more source
A case report of immune thrombocytopenic purpura as a rare Harbinger of Graves’ disease
Journal of Clinical and Translational Endocrinology Case Reports, 2022 Graves’ disease is one of the most common forms of autoimmune hyperthyroidism and has been linked with multiple or family histories of autoimmune diseases. In most cases, Graves' disease diagnosis is easily made by recognizing goiter, ophthalmopathy, and
Handoko Hariyono, Jongky Hendro Prajitno
doaj +1 more source
Epidemiology, management and outcomes of Graves’ disease—real life data. [PDF]
, 2017 PURPOSE: Treatment options in Graves' disease are clearly defined, but management practices and the perceptions of success are varied. The outcomes of treatment in large consecutive cohorts of Graves' disease have not been well characterised.
Allahabadia, A. +3 more
core +1 more source
Graves' Disease that Developed Shortly after Surgery for Thyroid Cancer [PDF]
Endocrinology and Metabolism, 2013 Graves' disease is an autoimmune disorder that may present with various clinical manifestations of hyperthyroidism. Patients with Graves' disease have a greater number of thyroid nodules and a higher incidence of thyroid cancer compared with patients ...
Hea Min Yu +3 more
doaj +1 more source
Patients' perceptions and views of surgery and radioiodine ablation in the definitive management of Graves' disease. [PDF]
, 2017 BACKGROUND: Patients' perceptions and preferences influence the choice of radioiodine ablation (RIA) or surgery in the definitive management of Graves' disease.
Allahabadia, A. +3 more
core +1 more source
The thyroid, the eyes and the gut: a possible connection [PDF]
, 2017 Graves’ disease (GD) is an autoimmune disorder responsible for 60–90% of thyrotoxicosis, with an incidence of 1 to 2 cases per 1000 population per year in England.
Covelli, D., Ludgate, Marian Elizabeth
core +2 more sources
Predicting remission of Graves' disease following treatment with antithyroid drugs
Клинический разбор в общей медицине, 2023 Graves' disease (GD) is among the most prevalent organ-specific diseases and is one of the most common causes of hyperthyroidism in regions with normal iodine supply.
Natalya V. Drogashevskaya +5 more
doaj +1 more source
Thyroid Research, 2019 Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of
Dorota Walasik-Szemplińska +2 more
doaj +1 more source
Kaohsiung Journal of Medical Sciences, 2006 The purpose of this study was to review the safety of total thyroidectomies for benign thyroid disease, with special emphasis on the comparison between Graves' disease and non-Graves' disease.
Feng-Yu Chiang +6 more
doaj +1 more source